Buprenorphine
Buprenorphine is one of 8,063 medications in the MedPlain dataset. Key details — Brand name: Buprenorphine; Generic name: BUPRENORPHINE; Manufacturer: Clinical Solutions Wholesale, LLC.
| Brand name | Buprenorphine |
|---|---|
| Generic name | BUPRENORPHINE |
| Manufacturer | Clinical Solutions Wholesale, LLC |
| Used for | 1 INDICATIONS AND USAGE Buprenorphine sublingual tablet is indicated for the treatment of opioid dependence and is preferred for induction. Buprenorphine sublingual tablet should be used as part of a complete treatment plan to include counseling and psychosocial support. Buprenorphine sublingual tablet, contains buprenorphine, a partial opioid agonist, and is indicated for the treatment of opioid dependence and is preferred for induction. (1) Buprenorphine sublingual tablet should be used as part of a complete treatment plan that includes counseling and psychosocial support. (1) |
| Dosage | 2 DOSAGE AND ADMINISTRATION Administer buprenorphine sublingual tablet sublingually as a single daily dose. (2.1) Strongly consider prescribing naloxone at the time buprenorphine sublingual tablet is initiated or renewed because patients being treated for opioid use disorder have the potential for relapse, putting them at risk for opioid overdose. (2.2) To avoid precipitating withdrawal, induction with buprenorphine sublingual tablet should be undertaken when objective and clear signs of withdra |
| Active ingredient(s) | BUPRENORPHINE HYDROCHLORIDE |
| Route | SUBLINGUAL |
| Official label | https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=023c7816-21b1-4f85-be36-9e32d5935c19 |